[Multidisciplinary treatment of carcinoma of the esophagus].
The recent amazing improvements in surgery for esophageal carcinoma which have been due largely to several factors such as pre- and postoperative management, surgical techniques, etc., have reduced the operative mortality. However, long term survival rates are not yet satisfactory. As more than 95% of patients with esophageal carcinoma are advanced carcinoma, multidisciplinary treatment is necessary. We have devised preoperative hyperthermo-chemo-radiotherapy, intraoperative local adjuvant chemotherapy, and postoperative long term cancer chemotherapy. Long term results of these combined therapy suggested the effectiveness of multidisciplinary treatment.
D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D006979:Hyperthermia, Induced
D001761:Bleomycin